The solution NMR structure of the transmembrane C-terminal domain of the amyloid precursor protein (C99)
SOLUTION NMR
| NMR Experiment | ||||||||
|---|---|---|---|---|---|---|---|---|
| Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
| 1 | 2D 1H-15N HSQC-TROSY | 10 % lyso myristoyl phosphatidylglycerol, 10 % [U-2H] D2O, 100 mM imidazole, 250 uM [U-100% 15N] APP_C99, 1 mM EDTA | 90% H2O/10% D2O | 6.5 | ambient | 318 | ||
| 2 | 3D HNCA | 10 % lyso myristoyl phosphatidylglycerol, 10 % [U-2H] D2O, 100 mM imidazole, 250 uM [U-100% 15N] APP_C99, 1 mM EDTA | 90% H2O/10% D2O | 6.5 | ambient | 318 | ||
| 3 | 3D HNCACB | 10 % lyso myristoyl phosphatidylglycerol, 10 % [U-2H] D2O, 100 mM imidazole, 250 uM [U-100% 15N] APP_C99, 1 mM EDTA | 90% H2O/10% D2O | 6.5 | ambient | 318 | ||
| 4 | 3D HN(CO)CA | 10 % lyso myristoyl phosphatidylglycerol, 10 % [U-2H] D2O, 100 mM imidazole, 250 uM [U-100% 15N] APP_C99, 1 mM EDTA | 90% H2O/10% D2O | 6.5 | ambient | 318 | ||
| 5 | 3D HN(COCA)CB | 10 % lyso myristoyl phosphatidylglycerol, 10 % [U-2H] D2O, 100 mM imidazole, 250 uM [U-100% 15N] APP_C99, 1 mM EDTA | 90% H2O/10% D2O | 6.5 | ambient | 318 | ||
| 6 | 3D HNCO | 10 % lyso myristoyl phosphatidylglycerol, 10 % [U-2H] D2O, 100 mM imidazole, 250 uM [U-100% 15N] APP_C99, 1 mM EDTA | 90% H2O/10% D2O | 6.5 | ambient | 318 | ||
| 7 | 3D gnoesyNhsqc | 10 % lyso myristoyl phosphatidylglycerol, 10 % [U-2H] D2O, 100 mM imidazole, 250 uM [U-100% 15N] APP_C99, 1 mM EDTA | 90% H2O/10% D2O | 6.5 | ambient | 318 | ||
| NMR Spectrometer Information | |||
|---|---|---|---|
| Spectrometer | Manufacturer | Model | Field Strength |
| 1 | Bruker | AMX | 800 |
| 2 | Bruker | AMX | 600 |
| 3 | Varian | INOVA | 900 |
| NMR Refinement | ||
|---|---|---|
| Method | Details | Software |
| molecular dynamics, simulated annealing | RESTRAINED MOLECULAR DYNAMICS WITH SIMULATED ANNEALING, FOLLOWED BY POWELL ENERGY MINIMIZATION | X-PLOR NIH |
| NMR Ensemble Information | |
|---|---|
| Conformer Selection Criteria | structures with the lowest energy |
| Conformers Calculated Total Number | 100 |
| Conformers Submitted Total Number | 30 |
| Representative Model | 1 (closest to the average) |
| Additional NMR Experimental Information | |
|---|---|
| Details | All 2D and 3D experiments were TROSY based. For the RDC data collection, the TROSY/Semi-TROSY method was used. |
| Computation: NMR Software | ||||
|---|---|---|---|---|
| # | Classification | Version | Software Name | Author |
| 1 | structure solution | X-PLOR NIH | 2.24 | Schwieters, Kuszewski, Tjandra and Clore |
| 2 | refinement | X-PLOR NIH | 2.24 | Schwieters, Kuszewski, Tjandra and Clore |
| 3 | data analysis | NMRDraw | Linux9 | Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax |
| 4 | data analysis | Sparky | 3.114 | Goddard |
| 5 | chemical shift assignment | Sparky | 3.114 | Goddard |
| 6 | peak picking | Sparky | 3.114 | Goddard |
| 7 | processing | NMRPipe | Linux9 | Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax |
| 8 | geometry optimization | TALOS | Linux9 | Cornilescu, Delaglio and Bax |
| 9 | structure solution | TALOS | Linux9 | Cornilescu, Delaglio and Bax |
| 10 | data analysis | ProcheckNMR | 3.5.4 | Laskowski and MacArthur |
| 11 | structure solution | ProcheckNMR | 3.5.4 | Laskowski and MacArthur |
| 12 | collection | TopSpin | 3 | Bruker Biospin |














